Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.(QUIT)股票分析

$6.060

-0.249 (-4.11%)收盘时

Loading chart…
最高
6.330
开盘
6.160
成交量加权均价
6.14
成交量
822.53K
市值
—
最低
6.037
成交额
5.05M
企业价值/息税折旧摊销前利润(TTM)
0.00

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

AI 分析 of Achieve Life Sciences, Inc. (QUIT)

买入

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

估值指标

Achieve Life Sciences, Inc.(QUIT)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

严重低估
5 年均值 P/S
20.19
当前P/S
20.19
高估
20.19
低估
20.19

持有 QUIT 的大户

T

TPG Capital, L.P.

+ 持有QUIT

+27.03%

3个月收益率

L

Logos Global Management, L.P.

+ 持有QUIT

+24.07%

3个月收益率

P

Paradigm Biocapital Advisors LP

+ 持有QUIT

+19.24%

3个月收益率

F

Frazier Life Sciences Management, LP

+ 持有QUIT

+10.54%

3个月收益率

V

VR Management, LLC

+ 持有QUIT

+9.81%

3个月收益率

QUIT 常见问题 —— 由 Alphio AI 解答

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

BDJ is a good buy right now due to its attractive 8.1% dividend yield and a solid 32% increase in dividends over the past decade, indicating strong income potential. Additionally, it is currently trading at an 8.2% discount, which could lead to price appreciation as market confidence improves. The main risk is its recent performance with a 1-day change of -0.31%, suggesting some short-term volatility.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易